Antitumoral activity of L-ascorbic acid-poly- D,L-(lactide-co-glycolide) nanoparticles containing violacein

References

• SofouSSurface-active liposomes for targeted cancer therapyNanomedicine2007271172417976032
   PubMed Web of Science ®Google Scholar
• SavonaMTalpazMGetting to the stem chronic myeloid leukaemiaNature Rev Cancer2008834135018385684
   PubMed Web of Science ®Google Scholar
• NarayanaAKellyPGolfinosJAntiangiogenic therapy using bevacizumab in recurrent high-grade glioma: impact on local control and patient survivalJ Neurosurg200911017318018834263
   PubMed Web of Science ®Google Scholar
• PaternotSRogerPPCombined inhibition of MEK and mammalian target of rapamycin abolishes phosphorylation of cyclin-dependent kinase 4 in glioblastoma cell lines and prevents their proliferationCancer Res2009694577458119458076
   PubMed Web of Science ®Google Scholar
• EgilmezNKKilincMOGuTControlled-release particulate cytokine adjuvants for cancer therapyEndocr Metab Immune Disord Drug Targets2007726627018220947
   PubMedGoogle Scholar
• NemunaitisJJGene immunotherapy for non-small cell lung cancerMethods Mol Biol200954249951419565919
   PubMedGoogle Scholar
• Douziech-EyrollesLMarchaisHHervéKNanovectors for anticancer agents based on superparamagnetic iron oxide nanoparticlesInt J Nanomedicine2007254155018203422
   PubMed Web of Science ®Google Scholar
• CiampiRVivaldiARomeiCExpression analysis of facilitative glucose transporters (GLUTs) in human thyroid carcinoma cell lines and primary tumorsMol Cell Endocrinol2008291576218571834
   PubMed Web of Science ®Google Scholar
• AgusDBVeraJCGoldeDWStromal cell oxidation: a mechanism by which tumors obtain vitamin CCancer Res1999184555455810493506
   PubMed Web of Science ®Google Scholar
• TorchilinVPMicellar nanocarriers: pharmaceutical perspectivesPharm Res20072411617109211
   PubMed Web of Science ®Google Scholar
• MarcatoPDDuránNNew aspects of nanopharmaceutical delivery systemsJ Nanosci Nanotechnol200882216222918572633
   PubMed Web of Science ®Google Scholar
• Har-elYEKatoYIntracellular delivery of nanocarriers for cancer therapyCurr Nanosci20073329338
   Web of Science ®Google Scholar
• ArrueboMFernández-PachecoRIbarraMRSantamaríaJMagnetic nanoparticles for drug deliveryNanotoday200722232
   Web of Science ®Google Scholar
• BharaliDJKhalilMGurbuzMSimoneTMMousaSANanoparticles and cancer therapy: A concise review with emphasis on dendrimersInt J Nanomedicine200941719421366
   PubMed Web of Science ®Google Scholar
• TekadeRKKumarPVJainNKDendrimers in oncology: An expanding horizonChem Rev2009109498719099452
   PubMed Web of Science ®Google Scholar
• NairLSLaurencinCTBiodegradable polymers as biomaterialsProgr Polym Sci200632762798
   Web of Science ®Google Scholar
• JainKKRecent advances in nanoocologyTechnol Cancer Res Treat2008711318198919
   PubMed Web of Science ®Google Scholar
• MundargiRCBabuVRRangaswamyVPatelPAminabhaviTMNano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivativesJ Control Release200812519320918083265
   PubMed Web of Science ®Google Scholar
• DuránNMenckCFChromobacterium violaceum: a review of pharmacological and industrial perspectivesCrit Rev Microbiol20012720122211596879
   PubMed Web of Science ®Google Scholar
• DuránNJustoGZFerreiraCVMeloPSCordiLMartinsDViolacein: properties and biological activitiesBiotechnol Appl Biochem20074812713317927569
   PubMed Web of Science ®Google Scholar
• FerreiraCVBosCLVersteegHHJustoGZDuránNPeppelenboschMPMolecular mechanism of violacein-mediated human leukemia cell deathBlood20041041459146415130948
   PubMed Web of Science ®Google Scholar
• de CarvalhoDDCostaFTMDuránNHaunMCytotoxic activity of violacein in human colon cancer cellsToxicol In Vitro2006201514152116889929
   PubMed Web of Science ®Google Scholar
• BrombergNJustoGZHaunMDuránNFerreiraCVViolacein cytotoxicity on human blood lymphocytes and effect on phosphatasesJ Enzyme Inhib Med Chem20052044945416335052
   PubMed Web of Science ®Google Scholar
• RettoriDDuránNProduction, extraction and purification of violacein: an antibiotic pigment produced byChromobacterium violaceumWorld J Microb Biotechnol199814685688
   Web of Science ®Google Scholar
• ItaliaJLYahyaMMSinghDRavi KumarMNBiodegradable nanoparticles improve oral bioavailability of amphotericin B and show reduced nephrotoxicity compared to intravenous FungizonePharm Res2009261324133119214716
   PubMed Web of Science ®Google Scholar
• MeloPSDe AzevedoMMFrugilloLAnazettiMCMarcatoPDDuránNNanocytotoxicity: violacein and violacein-loaded poly(D,L-lactide-co-glycolide) nanoparticles acting on human leukemic cellsJ Biomed Nanotechnol2009519220120055097
   PubMed Web of Science ®Google Scholar
• MartinsDCostaFTMBrocchiMEvaluation of the antibacterial activity of poly-(D,L-lactide-co-glycolide) nanoparticles containing violaceinJ Nanoparticle Res2009 Submission number: NANO2280
   Web of Science ®Google Scholar
• SuntornsukLGritsanapunWNilkamhankSPaochomAQuantitation of vitamin C content in herbal juice using direct titrationJ Pharm Biomed Anal2002288495512039626
   PubMed Web of Science ®Google Scholar
• FrungilloLMartinsDTeixeiraSAnazettiMCMelo PdaSDuránNTargeted antitumoral dehydrocrotonin nanoparticls with L-ascorbic acid 6-stearateJ Pharm Sci2009984796480719367621
   PubMed Web of Science ®Google Scholar
• ArranzNHazaAIGarcíaADelgadoMERafterJMoralesPInhibition by vitamin C of apoptosis induced by N-nitrosamines in HepG2 and HL-60 cellsJ Appl Toxicol20082878879618344201
   PubMed Web of Science ®Google Scholar
• LopesSCBlancoYCJustoGZViolacein extracted from Chromobacterium violaceum inhibits Plasmodium growth in vitro andin vivoAntimicrob Agents Chemother2009532149215219273690
   PubMed Web of Science ®Google Scholar
• CabaneBBlanchonSNevesCRecombination of nanometric vesicles during freeze-dryingLangmuir2006221982199016489779
   PubMed Web of Science ®Google Scholar
• LeeJChengYCritical freezing rate in freeze drying nanocrystal dispersionsJ Control Release200611118519216430987
   PubMed Web of Science ®Google Scholar
• HolzerMVogelVMänteleWSchwartzDHaaseWLangerKPhysico-chemical characterisation of PLGA nanoparticles after freeze-drying and storageEur J Pharm Biopharm20097242843719462479
   PubMed Web of Science ®Google Scholar
• ChenQEspeyMGSunAYAscorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluidin vivoProc Natl Acad Sci U S A20071048749875417502596
   PubMed Web of Science ®Google Scholar
• YuBZhaoXLeeLJLeeRJTargeted delivery systems for oligonucleotide therapeuticsAAPS J20091195203
   Web of Science ®Google Scholar
• ChenHAhnRVan den BosscheJThompsonDHO’HalloranTVFolate-mediated intracellular drug delivery increases the anticancer efficacy of nanoparticulate formulation of arsenic trioxideMol Cancer Ther200981955196319567824
   PubMed Web of Science ®Google Scholar
• MachedaMLRogersSBestJDMolecular and cellular regulation of glucose transporter (GLUT) proteins in cancerJ Cell Physiol200520265466215389572
   PubMed Web of Science ®Google Scholar
• AirleyREMobasheriAHypoxic regulation of glucose transport, anaerobic metabolism and angiogenesis in cancer: novel pathways and targets for anticancer therapeuticsChemotherapy20075323325617595539
   PubMed Web of Science ®Google Scholar
• FonteynePCasneufVPauwelsPExpression of hexokinases and glucose transporters in treated and untreated oesophageal adenocarcinomaHistol Histopathol20092497197719554504
   PubMed Web of Science ®Google Scholar
• DaskalowKPfanderDWeichertWDistinct temporospatial expression patterns of glycolysis-related proteins in human hepatocellular carcinomaHistochem Cell Biol2009132213119350262
   PubMed Web of Science ®Google Scholar